LIPOSOME TECHNOLOGY INC /DE/
10-C, 1995-06-06
PHARMACEUTICAL PREPARATIONS
Previous: CMS ENERGY CORP, S-4, 1995-06-06
Next: SAHARA GAMING CORP, 8-K, 1995-06-06



<PAGE>

                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                    FORM 10-C

                REPORT BY INSURER OF SECURITIES QUOTED ON NASDAQ
                          INTERDEALER QUOTATION SYSTEM
                  FILED PURSUANT TO SECTION 13 OR 15(d) OF THE
                 SECURITIES EXCHANGE ACT OF 1934 AND RULE 13a-17
                              OR 15d-17 THEREUNDER


                            LIPOSOME TECHNOLOGY, INC.
- -------------------------------------------------------------------------------
                 (Exact name of insurer as specified in charter)

                    960 HAMILTON COURT, MENLO PARK, CA 94025
- -------------------------------------------------------------------------------
                    (Address of principal executive offices)

Issuer's telephone number, including area code (415) 323-9011
                                              --------------

I.   CHANGE IN NUMBER OF SHARES OUTSTANDING

Indicate any change (increase or decrease) of five percent or more in the number
of shares outstanding:

1.   Title of security COMMON STOCK
                       --------------------------------------------------------

2.   Number of shares outstanding before the change 19,155,400
                                                    ---------------------------

3.   Number of shares outstanding after the change 21,379,111
                                                   ----------------------------

4.   Effective date of change  MAY 25, 1995
                               ------------------------------------------------

5.   Method of change:   Specify method (such as merger, acquisition, exchange,
                         distribution, stock split, acquisition of stock for
                         treasury, etc.)
     PRIVATE PLACEMENT
- -------------------------------------------------------------------------------

Give brief description of transaction SALE OF 2,223,711 UNITS, EACH CONSISTING
OF ONE SHARE OF COMMON STOCK AND A NON-TRANSFERABLE WARRANT TO PURCHASE ONE-HALF
SHARE OF COMMON STOCK, THROUGH PRIVATE PLACEMENT.


                          II. CHANGE IN NAME OF INSURER

1.   Name prior to change
                          -----------------------------------------------------

2.   Name after change
                       --------------------------------------------------------

3.   Effective date of charter amendment changing name
                                                       ------------------------

4.   Date of shareholder approval of change, if required
                                                          ---------------------

Date June 2, 1995                       /s/ DONALD J. STEWART, V.P. FINANCE
     -----------------------------      ---------------------------------------
                                          (OFFICER SIGNATURE AND TITLE)





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission